Studies have found that adiponectin can inhibit the accumulation of β - Catenin in pancreatic cancer cells by inactivating GSK-3β, thereby reducing the expression of cyclin D1 and leading to arrest of the pancreatic cancer cell cycle in G-G phase, which plays a protective role in pancreatic cancer (62). Here, ADIPOQ is linked to pancreatic neoplasm.